Paul W. Hoelscher - 20 Jan 2022 Form 3 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role
Director
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Issuer symbol
OKUR
Transactions as of
20 Jan 2022
Net transactions value
$0
Form type
3
Filing time
24 Jan 2022, 15:55:50 UTC
Previous filing
06 Jan 2022
Next filing
24 Jan 2022

No securities are beneficially owned.